Table of Contents

Transcriptional Regulation of De Novo Lipogenesis in Liver.- The Molecular Basis of Hepatic De Novo Lipogenesis in Insulin Resistance.- Regulation of Hepatic Metabolism by the Mechanistic Target of Rapamycin.- FoxO1: A Conductor of Insulin Signaling to Glucose and Lipid Metabolism.- Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease.- Role of the Endocannabinoid System in Hepatic Lipogenesis.- Role of Lipogenesis and Lipid Desaturases in Non-Alcoholic Fatty Liver Disease.- Lipid Droplet Proteins and Lipid Metabolism.- Influence of Gut Microbiota on Hepatic Lipogenesis and Disease Pathogenesis.- Hepatic Lipogenesis: Nutritional Control and Pathophysiological Relevance.- Metabolic Rhythm of Hepatic Lipogenesis: Regulation and Roles in Metabolism.- Monounsaturated Fatty Acid Mediated Liver-adipose Tissue Crosstalk and Metabolic Regulation.- Adipose Tissue DNL and Its Role in Metabolic Homeostasis.- The Lipogenic Effect of Insulin Revisited.- Index. 

About the Author

James M. Ntambi, PhD, is the Katherine Berns Von Donk Steenbock Professor in Nutrition, Department of Chemistry, College of Agricultural and Life Sciences, at the University of Wisconsin, Madison.